Actively Recruiting

Phase Not Applicable
Age: 7Years - 18Years
All Genders
NCT04934293

Virtual Reality for Children in Radiotherapy (REVER)

Led by Centre Antoine Lacassagne · Updated on 2025-05-07

47

Participants Needed

1

Research Sites

287 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

For a young patient, the conditions of proton therapy treatment can be stressful. Adjusting the environment can be a source of avoiding this physical and psychological discomfort impacting the quality of treatment. A fixed, long, uncomfortable position is the main cause of stress, already present due to the cancerous therapeutic course. It extends the positioning time. For the patient and the optimization of his treatment, solutions must be sought. Relaxation in virtual reality is efficient, simple and non-medicinal and could reduce stress in children and allow irradiation in very good conditions. We will assess the effectiveness of the virtual reality session using objective (placement time, helmet tolerance) and subjective (perceived anxiety via a dedicated questionnaire) criteria. This is the first pediatric virtual reality study, supported by the French Group of Pediatric Radiotherapists, to reduce anxiety in radiotherapy. Multiple benefits from this pilot study are expected, such as improved reception conditions, treatment parameters and better acceptance of proton therapy sessions.

CONDITIONS

Official Title

Virtual Reality for Children in Radiotherapy (REVER)

Who Can Participate

Age: 7Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient treated at the Antoine LACASSAGNE Center for proton therapy
  • Age 7 years or older and 18 years or younger
  • Patient and parents (if minor) have read the information notice and signed informed consent
  • Patient has social security coverage
Not Eligible

You will not qualify if you...

  • Age younger than 7 years or older than 18 years
  • Patient under general anesthesia
  • Patient has wounds or infections on the head incompatible with using the VR headset
  • Patient has respiratory problems
  • Patient has severe claustrophobia
  • Patient is being treated for a psychiatric condition
  • Patient has uncontrolled epilepsy
  • Patient has visual (binocular) or hearing problems preventing VR use
  • Patient's head size is too small for the VR headset
  • Patient is receiving combined radio chemotherapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centre Antoine Lacassagne

Nice, France

Actively Recruiting

Loading map...

Research Team

A

Amandine STARZYK

CONTACT

P

Pierre-Yves BONDIAU, M.D, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here